PARAMETRIC PORTFOLIO ASSOCIATES LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$3,258,000
-2.6%
94,062
-17.7%
0.00%0.0%
Q4 2021$3,346,000
+35.5%
114,309
+17.9%
0.00%
+100.0%
Q3 2021$2,469,000
-3.3%
96,918
+32.9%
0.00%0.0%
Q2 2021$2,553,000
+44.0%
72,901
+67.6%
0.00%0.0%
Q1 2021$1,773,000
-6.6%
43,499
-0.7%
0.00%0.0%
Q4 2020$1,898,000
-25.6%
43,823
-5.3%
0.00%
-50.0%
Q3 2020$2,552,000
-39.3%
46,288
-30.5%
0.00%
-33.3%
Q2 2020$4,205,000
+73.4%
66,608
+40.3%
0.00%
+50.0%
Q1 2020$2,425,000
-46.7%
47,475
-17.1%
0.00%
-33.3%
Q4 2019$4,550,000
+129.0%
57,239
+39.8%
0.00%
+50.0%
Q3 2019$1,987,000
-15.8%
40,945
-8.7%
0.00%0.0%
Q2 2019$2,360,000
+331.4%
44,866
+334.5%
0.00%
Q1 2019$547,000
+108.8%
10,325
+62.0%
0.00%
Q4 2018$262,000
+30.3%
6,374
+20.3%
0.00%
Q3 2018$201,000
-32.6%
5,297
-19.6%
0.00%
Q2 2018$298,000
-78.1%
6,592
-76.6%
0.00%
-100.0%
Q1 2018$1,358,000
+15.6%
28,113
-5.9%
0.00%0.0%
Q4 2017$1,175,000
+5.3%
29,868
-16.9%
0.00%0.0%
Q3 2017$1,116,000
+31.9%
35,927
+16.1%
0.00%0.0%
Q2 2017$846,000
-25.1%
30,943
+0.9%
0.00%
-50.0%
Q1 2017$1,130,00030,6590.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders